Neural Cell News Volume 17.10 | Mar 15 2023

    0
    24







    2023-03-15 | NCN 17.10


    Neural Cell News by STEMCELL Technologies
    Vol. 17.10 – 15 March, 2023
    TOP STORY

    An Airway-to-Brain Sensory Pathway Mediates Influenza-Induced Sickness

    Using genetic tools that broadly covered a peripheral sensory neuron atlas, scientists identified a small population of prostaglandin E2 -detecting glossopharyngeal sensory neurons that were essential for influenza-induced sickness behavior in mice.
    [Nature]

    Full ArticlePress Release
    PUBLICATIONSRanked by the impact factor of the journal

    Microglia-Mediated T Cell Infiltration Drives Neurodegeneration in Tauopathy

    Researchers compared the immunological milieux in the brain of mice with amyloid deposition or tau aggregation and neurodegeneration, to investigate the role of the adaptive immune response and its interaction with the innate immune response in the presence of amyloid-β or tau pathology.
    [Nature]

    AbstractPress Release

    SOX11 Regulates SWI/SNF Complex Components as Member of the Adrenergic Neuroblastoma Core Regulatory Circuitry

    Scientists identified SOX11 as a dependency transcription factor in adrenergic neuroblastoma based on recurrent chromosome 2p focal gains and amplifications, specific expression in the normal sympatho-adrenal lineage, and strong dependency on high SOX11 expression in adrenergic neuroblastomas.
    [Nature Communications]

    Full Article

    Endothelial Arid1a Deletion Disrupts the Balance among Angiogenesis, Neurogenesis and Gliogenesis in the Developing Brain

    Investigators suggested that endothelial Arid1a tightly controls the fate determination of neural progenitor cells by regulating the AKT-SMAD signaling pathway.
    [Cell Proliferation]

    Full Article

    Quinpirole Ameliorates Nigral Dopaminergic Neuron Damage in Parkinson’s Disease Mouse Model through Activating GHS-R1a/D2R Heterodimers

    Researchers investigated the existence and function of Growth hormone secretagogue receptor 1a/dopamine type 2 receptor (GHS-R1a/D2R) heterodimers in nigral dopaminergic neurons in Parkinson’s disease models in vitro and in vivo.
    [Acta Pharmacologica Sinica]

    Full Article

    Microglial cGAS Drives Neuroinflammation in the MPTP Mouse Models of Parkinson’s Disease

    Scientists observed that the cGAS-STING pathway was activated during neuroinflammation in MPTP mouse models of Parkinson’s diease.
    [CNS Neuroscience & Therapeutics]

    Full Article

    Nigrosome 1 Visibility and Its Association with Nigrostriatal Dopaminergic Loss in Parkinson’s Disease

    Investigators determined the threshold of regional specific binding ratio (SBR) for discriminating Nigrosome 1 (NG1) visibility and the probability for NG1 visibility according to regional SBR.
    [European Journal Of Neurology]

    Full Article

    Verteporfin-Induced Proteotoxicity Impairs Cell Homeostasis and Survival in Neuroblastoma Subtypes Independent of YAP/TAZ Expression

    Researchers showed significant in vitro and in vivo Verteporfin–induced suppression of neuroblastoma growth, making Verteporfin a potential therapeutic candidate against neuroblastomas.
    [Scientific Reports]

    Full Article

    Convergent Coexpression of Autism-Associated Genes Suggests Some Novel Risk Genes May Not Be Detectable in Large-Scale Genetic Studies

    Scientists demonstrated that coexpression patterns from 993 human postmortem brains were significantly correlated with the transcriptional consequences of CRISPR perturbations in human neurons.
    [Cell Genomics]

    Full ArticleGraphical Abstract
    STEMCELL's Neural Crest Differentiation Kit enables high-purity generation of neural crest precursors from human pluripotent stem cells.
    REVIEWS

    The Molecular Pathology of Schizophrenia: An Overview of Existing Knowledge and New Directions for Future Research

    The authors overview the current knowledge acquired from studies of brains modeling six identified single genes, their limitations, and directions for future research that may redefine schizophrenia based on biological alterations in the responsible organ rather than operationalized criteria.
    [Molecular Psychiatry]

    Full Article
    INDUSTRY AND POLICY NEWS

    SciSparc Receives Approval to Conduct Its Phase IIb Clinical Trial for SCI-110 to Treat Tourette Syndrome

    SciSparc Ltd. announced the approval of the Israeli Ministry of Health to conduct its clinical trial titled “A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy, safety and tolerability of daily oral SCI-110 in treating adults with Tourette Syndrome”.
    [SciSparc, Ltd.(Globe Newswire, Inc.)]

    Press Release
    FEATURED EVENT

    Autophagy and Neurodegeneration: Mechanisms to Therapies

    March 26 – 29, 2023
    Snowbird, Utah, United States

    > See All Events

    JOB OPPORTUNITIES

    Staff Scientist – Pediatric Brain Tumors

    Dana-Farber Cancer Institute – Bostona, Massachusetts, United States

    Postdoctoral Position – Soft Implantable Neural Systems

    Swiss Federal Institute of Technology Lausanne – Lausanne, Switzerland

    Postdoctoral Scholar – Cell Programming

    University of Southern California – Los Angeles, California, United States

    Computational Biologist – Cancer and Glioma Stem Cell Biology

    Weill Cornell College of Medicine – New York, New York, United States

    Postdoctoral Position – Alzheimer’s Disease & Protein Aggregation Research

    University of Luxembourg – Esch-sur-Alzette, Luxembourg

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Neural Cell News Twitter